Safety, Tolerability and Efficacy of ZD6126 in Combination With Oxaliplatin, 5-Fluorouracil and Leucovorin in Subjects With Metastatic Colorectal Cancer.

PHASE2TerminatedINTERVENTIONAL

Enrollment

180

Participants

Timeline

Start Date

September 30, 2003

Primary Completion Date

February 29, 2004

Study Completion Date

February 29, 2004

Conditions

Colorectal NeoplasmsMetastases, Neoplasm

Interventions

DRUG

ZD6126

DRUG

Placebo

DRUG

5-fluorouracil

DRUG

leucovorin

DRUG

oxaliplatin

Trial Locations (10)

Research Site, Los Angeles

Research Site, San Francisco

Research Site, Chicago

Research Site, New Orleans

Research Site, Baltimore

Research Site, St Louis

Research Site, New York

Research Site, Chapel Hill

Research Site, Durham

Research Site, Pittsburgh